Effectiveness and Safety of Implantable Neurostimulation Systems for Chronic Pain: A Spanish Multicenter Study (STIM-RENASED)
NCT ID: NCT05770700
Last Updated: 2024-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
504 participants
OBSERVATIONAL
2023-04-01
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Smartphone App for Chronic Pain Management
NCT03678155
Effects of Pain Neuroscience Education and Virtual Reality in Patients With Chronic Low Back Pain
NCT06410027
Pain Inhibitory Effects of a Single Painful Mechanical Stimulus Compared to Multiple and Multiple at Different Locations
NCT05730179
Multidisciplinary Intervention for Non-Cancer Chronic Pain: Pilot Study
NCT07273084
Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain
NCT01850875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Accept to participate in the study and sign informed consent.
Exclusion Criteria
* Insufficient understanding of the Spanish language.
* Pregnancy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sociedad Espanola del Dolor
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital FREMAP Majadahonda
Majadahonda, Madrid, Spain
Complejo Hospitalario Universitario de Cartagena
Cartagena, Murcia, Spain
Hospital Universitario de Navarra
Pamplona, Navarre, Spain
Hospital Clinic de Barcelona
Barcelona, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Universitario Vall d'Hebron
Barcelona, , Spain
Hospital Universitario Puerta del Mar
Cadiz, , Spain
Hospital General Universitario Gregorio Marañón
Madrid, , Spain
Hospital Universitario de La Princesa
Madrid, , Spain
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, , Spain
Hospital Regional Univeristario de Málaga
Málaga, , Spain
Complexo Hospitalario Univeritario de Ourense
Ourense, , Spain
Hospital Universitari Son Espases
Palma de Mallorca, , Spain
Hospital Universitario Virgen del Rocío
Seville, , Spain
Hospital Universitari i Politècnic La Fe
Valencia, , Spain
Complejo Hospitalario Universitario de Vigo
Vigo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rogelio Rosado, MD
Role: primary
María Luz Padilla del Rey, MD
Role: primary
Laura Gómez Glia, MD
Role: primary
Miren Revuelta, MD, PhD
Role: primary
Anna Server, MD
Role: primary
Jose Manuel Trinidad Martín-Arroyo, MD
Role: primary
Angel Alonso, MD
Role: primary
Concepción Pérez, MD, PhD
Role: primary
Agustin Mendiola, MD, PhD
Role: primary
Mariano Fernández Baena, MD
Role: primary
Luz Cánovas Martínez, MD
Role: primary
Hermann Ribera Leclerc, MD
Role: primary
Isaac Peña, MD
Role: primary
Maria Ángeles Canós Verdecho, MD
Role: primary
Alfonso Carrregal, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI 238/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.